|
|
Article: New Studies Show Actonel Rapidly Reduces Vertebral Fracture Risk in Just One Year.
- Article from:
- PR Newswire
- Article date:
- June 19, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- Evidence of Rapid Progression of Osteoporosis Calls For
Paradigm Shift in Treatment -
- Actonel Is the Only Therapy Proven to Reduce
Vertebral Fractures in Just One Year -
CHICAGO, June 19 /PRNewswire/ --
Results from five studies presented today at the World Congress on Osteoporosis (WCO) show that treatment with the new osteoporosis drug Actonel(R) (risedronate sodium tablets) consistently reduced the risk of vertebral (spinal) fractures in just one year across a patient population with varying degrees of osteoporotic disease severity. The WCO, which is held every four years, is co-sponsored by the International ...